- Home
- ASYS vs ATNM Comparison
ASYS vs ATNM Comparison
Compare ASYS & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- ATNM
- Stock Information
- Founded
- ASYS 1981
- ATNM 2000
- Country
- ASYS United States
- ATNM United States
- Employees
- ASYS N/A
- ATNM N/A
- Industry
- ASYS Industrial Machinery/Components
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- ASYS Technology
- ATNM Health Care
- Exchange
- ASYS Nasdaq
- ATNM Nasdaq
- Market Cap
- ASYS 59.4M
- ATNM 51.5M
- IPO Year
- ASYS N/A
- ATNM N/A
- Fundamental
- Price
- ASYS $4.48
- ATNM $1.47
- Analyst Decision
- ASYS
- ATNM Strong Buy
- Analyst Count
- ASYS 0
- ATNM 3
- Target Price
- ASYS N/A
- ATNM $4.67
- AVG Volume (30 Days)
- ASYS 33.8K
- ATNM 518.4K
- Earning Date
- ASYS 08-06-2025
- ATNM 08-04-2025
- Dividend Yield
- ASYS N/A
- ATNM N/A
- EPS Growth
- ASYS N/A
- ATNM N/A
- EPS
- ASYS N/A
- ATNM N/A
- Revenue
- ASYS $90,826,000.00
- ATNM N/A
- Revenue This Year
- ASYS N/A
- ATNM N/A
- Revenue Next Year
- ASYS $28.60
- ATNM N/A
- P/E Ratio
- ASYS N/A
- ATNM N/A
- Revenue Growth
- ASYS N/A
- ATNM N/A
- 52 Week Low
- ASYS $3.20
- ATNM $1.03
- 52 Week High
- ASYS $6.96
- ATNM $8.64
- Technical
- Relative Strength Index (RSI)
- ASYS 59.76
- ATNM 44.59
- Support Level
- ASYS $4.33
- ATNM $1.41
- Resistance Level
- ASYS $4.68
- ATNM $1.49
- Average True Range (ATR)
- ASYS 0.26
- ATNM 0.12
- MACD
- ASYS 0.02
- ATNM -0.02
- Stochastic Oscillator
- ASYS 70.51
- ATNM 25.00
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.